Bayer Gets Chance To Appeal Xarelto Patent Loss
Bayer AG can appeal a High Court decision that nixed a patent for its blockbuster drug Xarelto in the U.K., the U.K. judiciary confirmed on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article